Press releases

• 2020-07-06

  NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer

  STOCKHOLM - July 6, 2020. NeoDynamics AB (Spotlight Stock Market: NEOD), announces that the Company restarts patient recruitment to the UK COMPULSE Study following a temporary pause imposed by the COVID-19 pandemic. Read more

• 2020-05-26

  NeoDynamics AB (publ) First Quarter 2020

  Somewhat higher development cost, but mainly in line Read more

• 2020-02-05

  NeoDynamics AB (publ) full-year report 2019

  Summing up a productive 2019 Read more

• 2020-02-03

  A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.

  Associate professor Edward Azavedo has performed a retrospective study at Karolinska Hospital, where he analyzed tissue samples using NeoDynamics’ new biopsy system, NeoNavia. An abstract with the initial study results has been accepted by SBI for presentation at their annual meeting in Denver, April 16-19, 2020. Read more

• 2020-01-28

  NeoDynamics AB (publ) receives notification of granted patent on biopsy instrument in China

  The expected announcement from the Chinese patent authority means that NeoDynamics´ unique biopsy device with front-loaded needle and integrated trocar, an important component of the NeoNavia® biopsy system is approved. The patent increases the protection of the NeoNavia biopsy system, which further strengthens the competitiveness. Read more